DSM to acquire Ocean Nutrition Canada to expand its Nutritional Lipids growth platform
Royal DSM, the global Life Sciences and Materials Sciences company, announced on Friday, 18 May 2012 that it has entered into a definitive agreement with Clearwater Fine Foods and funds managed by Richardson Capital to acquire Ocean Nutrition Canada for a total enterprise value of CAD 540 million. Subject to customary conditions, the transaction is expected to close in H2 2012. More>
Conference calls Ocean Nutrition Canada acquisition
On Friday, 18 May 2012 DSM held a conference call for investors and analysts. You may listen to a recording at the action replay number +31 10 29 44 210 followed by the pass code 1195532#. Also more information can be found in the Investor Relations presentation or in the press release.
MP3 Analysts Conference Call
-1.82%
Subscribe to DSM's RSS feeds
You can subscribe to RSS feeds of DSM's Corporate Press Releases and/or notification of forthcoming events.
Press releases
-
DSM commences tender offer for Kensey Nash
21 May 2012 at 08:15 CET
-
DSM to acquire Ocean Nutrition Canada to expand its Nutritional Lipids growth platform
18 May 2012 at 07:15 CET
High Growth Economies: from reaching out to being truly global
All the evidence indicates that fast-growing economies such as China, India, Brazil and Russia and other emerging areas will be the major global growth engines for the world economy over the next decade. DSM has actively pursued growth opportunities in high growth economies across all businesses. In the past five years the share of sales from these economies has increased from 22% in 2005 to about 32%. DSM has built a strong local presence in different regions in the last few years. A significant factor in DSM’s Vision 2010 was the fact that DSM exceeded the ambitious sales growth target of USD 1.5 billion in China (in 2007 this target was increased from USD 1.0 billion). More>
Innovation: from ‘building the machine’ to doubling innovation output
Building on its track record, DSM aspires to take value creation through innovation to the next level. This will be visible, among other things, through an even higher speed of innovation and consequently a new stretching innovation target and an ambitious growth perspective for the Emerging Business Areas (EBAs) DSM Bio-based Products & Services, DSM Biomedical and DSM Advanced Surfaces. DSM aims to increase innovation sales from 12% towards 20% of total sales by 2015. This target reflects DSM’s aspiration to further boost innovative growth as well as portfolio renewal and the speed of innovation. The EBAs should grow to a combined turnover of more than € 1 billion in 2020. More>
Sustainability: from responsibility to a business driver
DSM is consciously expanding its sustainability approach. From an internal value and a tool for making a responsible contribution to society, sustainability has become a strategic business driver. DSM has set new and ambitious targets and aspirations for sustainability. To achieve these ambitious goals, sustainability is increasingly being embedded into all of DSM’s business activities. More>
Acquisitions & Partnerships: from ‘portfolio transformation’ to ‘driving focused growth’
DSM applies stringent strategic, financial and sustainability criteria to any potential acquisition or partnership. In the screening process a first selection is made on the basis of strategic fit. This results in a shortlist to which DSM applies its financial criteria. A key strategic criterion is that the business or partner should add or increase a leadership position and should add value to DSM in terms of technological and/or market competencies. DSM will also look for opportunities to strengthen competencies and market positions for the other three strategic growth drivers: expansion in High Growth Economies, Innovation and Sustainability. As DSM is fully committed to maintaining its Single A credit rating, the key financial criterion is that any acquisition should be cash earnings per share accretive from the beginning and should be supportive to the other financial targets. More>
